UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F | ☐ | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 | | --- | --- | | | OR | | ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the fiscal year ended December 31, 2022 | | | OR | | ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | OR | | ☐ | SHELL COMPANY REPORT PURSUANT TO SECTION ...

Exhibit 99.2 EVOGENE LTD. 13 Gad Feinstein St., Park Rehovot P.O.B. 4173, Ness Ziona, 7414003, Israel PROXY STATEMENT 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS This Proxy Statement is being furnished in connection with the solicitation of proxies on behalf of the Board of Directors, or the Board, of Evogene Ltd., to which we refer as Evogene or the Company, to be voted at the 2023 Annual General Meeting of Shareholders of the Company, or the Meeting, and at any adjournment thereof, pursuant to the Notice ...

Evogene Ltd. (NASDAQ:EVGN) Q4 2022 Earnings Conference Call March 9, 2023 9:00 AM ET Company Participants Ofer Haviv - Chief Executive Officer Eyal Ronen - Executive Vice President, Business Development Yaron Eldad - Chief Financial Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald Brett Reiss - Janney Montgomery Scott Brian Wright - ROTH Capital Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene’s Fourth Quarter and Full Year 2022 Results Conference Call. All ...

Start Time: 09:00 January 1, 0000 9:34 AM ET Evogene Ltd. (NASDAQ:EVGN) Q3 2022 Earnings Conference Call November 17, 2022, 09:00 AM ET Company Participants Ofer Haviv - President and CEO Yaron Eldad - CFO Conference Call Participants Kristen Kluska - Cantor Fitzgerald Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene's Third Quarter 2022 Results Conference Call. All participants are at present in listen-only mode. Following management's formal presentation, instructions will be g ...

Evogene Ltd. (NASDAQ:EVGN) Q2 2022 Earnings Conference Call August 31, 2022 9:00 AM ET Â Company Participants Ofer Haviv - President & CEO Russ Putland - EVP Commercial & General Manager, Lavie-Bio, Inc. Yaron Eldad - CFO Conference Call Participants Kristen Kluska - Cantor Fitzgerald Brian Wright - ROTH Capital Partners Brett Reiss - Janney Montgomery Scott Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene's Second Quarter 2022 Results Conference Call. All participants are presen ...

Evogene Ltd. (NASDAQ:EVGN) Q1 2022 Results Conference Call May 26, 2022 9:00 AM ET Company Participants Ofer Haviv - CEO, President & Chairman Elran Haber - CEO, Biomica Yaron Eldad - CFO Conference Call Participants Kristen Kluska - Cantor Fitzgerald Nathan Weinstein - Aegis Capital Brett Reiss - Janney Montgomery Scott Brian Wright - ROTH Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene's First Quarter 2022 Results Conference Call. All participants are present in a listen-only ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each class Trading symbol(s) Name of each exchange on which registered Ordinary shares, par value NIS 0.02 per share EVGN Nasdaq Stock Market LLC FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1 ...

Evogene Ltd. (NASDAQ:EVGN) Q3 2021 Earnings Conference Call November 17, 2021 9:00 AM ET Â Company Participants Ofer Haviv - President, Chief Executive Officer Arnon Heyman - Chief Executive Officer, Canonic Dorit Kreiner - Chief Financial Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald Nathan Weinstein - Aegis Capital Brett Reiss - Janney Montgomery Scott Brian Wright - Roth Capital Partners Operator Ladies and gentlemen, thank you for standing by. Welcome to EvogeneÂ's third quarte ...

| --- | --- | --- | --- | |-------|-------|-------|-------| | | | | | | | | | | Forward Looking Statement This presentation contains "forward-looking statements" relating to future events, and Evogene Ltd (the "Company"), may from time to time make other statements, regarding our outlook or expectations for future financial or operating results and/or other matters regarding or affecting us that are considered "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 19 ...

Evogene Ltd. (NASDAQ:EVGN) Q2 2021 Results Conference Call August 11, 2021 9:00 AM ET Company Participants Ofer Haviv – President and Chief Executive Officer Dorit Kreiner – Chief Financial Officer Sarit Firon – Chairperson of the Board Conference Call Participants Kristen Kluska – Cantor Fitzgerald Ben Klieve – Lake Street Nathan Weinstein – Aegis Capital Geoff Gilbert – Inukshuk Kenny Green – Edison Group Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene's Second Quarter 2021 Re ...